Tue 06/11/2019 06:00 AM
Share this article:
Relevant Documents:
Complaint; PI Motion / Brief / Declaration
U.S. Settlement Stipulation and Motion
Estimation Procedures Motion / Declaration
Bidding Procedures Motion / Declaration
Bar Date Motion

As expected, the Insys Therapeutics debtors continued to file first day pleadings Monday evening, June 10, in furtherance of their three-prong strategy: “(i) maximizing the value of their enterprise through pursuing a sale of their assets and pursuing affirmative causes of action;...
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!